Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Dec;79(24):7547-55.
doi: 10.1128/AEM.02229-13. Epub 2013 Oct 11.

Bacteriophage orphan DNA methyltransferases: insights from their bacterial origin, function, and occurrence

Affiliations
Review

Bacteriophage orphan DNA methyltransferases: insights from their bacterial origin, function, and occurrence

James Murphy et al. Appl Environ Microbiol. 2013 Dec.

Abstract

Type II DNA methyltransferases (MTases) are enzymes found ubiquitously in the prokaryotic world, where they play important roles in several cellular processes, such as host protection and epigenetic regulation. Three classes of type II MTases have been identified thus far in bacteria which function in transferring a methyl group from S-adenosyl-l-methionine (SAM) to a target nucleotide base, forming N-6-methyladenine (class I), N-4-methylcytosine (class II), or C-5-methylcytosine (class III). Often, these MTases are associated with a cognate restriction endonuclease (REase) to form a restriction-modification (R-M) system protecting bacterial cells from invasion by foreign DNA. When MTases exist alone, which are then termed orphan MTases, they are believed to be mainly involved in regulatory activities in the bacterial cell. Genomes of various lytic and lysogenic phages have been shown to encode multi- and mono-specific orphan MTases that have the ability to confer protection from restriction endonucleases of their bacterial host(s). The ability of a phage to overcome R-M and other phage-targeting resistance systems can be detrimental to particular biotechnological processes such as dairy fermentations. Conversely, as phages may also be beneficial in certain areas such as phage therapy, phages with additional resistance to host defenses may prolong the effectiveness of the therapy. This minireview will focus on bacteriophage-encoded MTases, their prevalence and diversity, as well as their potential origin and function.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Potential advantageous effects of phage-encoded orphan MTases (see text for further details). (A) Methylation of the GATC sites within the pac region of the phage P1 genome by a self-encoded DAM MTase facilitates the efficient release of progeny phage. Generation of both dam mutant hosts and dmt phage (phage DAM knockout) prevents methylation of the phage DNA during packaging, leading to a decreased level of phage progeny released. (B) Protection of phage genomes from host-encoded restriction endonucleases through the protection afforded by the phage-encoded orphan MTase. (C) DAM methylation is essential for lysogeny of the Shiga toxin-encoding phage 933W and release of Shiga toxin by EHEC. Loss of GATC methylation results in release of integrated phage and loss of Shiga toxin production by EHEC. Me, methyl group.
Fig 2
Fig 2
Genomic organization of lactococcal phage Tuc2009, Brucella phage Tb, and Pseudomonas phage B3 highlighting examples of orphan MTases and flanking genes to show that orphan MTases can be found in different locations in a given phage genome (regions encoding predicted structural and replication proteins).
None
None
None
None
None

References

    1. Roberts RJ, Vincze T, Posfai J, Macelis D. 2010. REBASE–a database for DNA restriction and modification: enzymes, genes and genomes. Nucleic Acids Res. 38:D234–D236 - PMC - PubMed
    1. Labrie SJ, Samson JE, Moineau S. 2010. Bacteriophage resistance mechanisms. Nat. Rev. Microbiol. 8:317–327 - PubMed
    1. Pingoud A, Fuxreiter M, Pingoud V, Wende W. 2005. Type II restriction endonucleases: structure and mechanism. Cell. Mol. Life Sci. 62:685–707 - PMC - PubMed
    1. Youell J, Firman K. 2012. Mechanistic insight into type I restriction endonucleases. Front. Biosci. 17:2122–2139 - PubMed
    1. Roberts RJ, Belfort M, Bestor T, Bhagwat AS, Bickle TA, Bitinaite J, Blumenthal RM, Degtyarev S, Dryden DT, Dybvig K, Firman K, Gromova ES, Gumport RI, Halford SE, Hattman S, Heitman J, Hornby DP, Janulaitis A, Jeltsch A, Josephsen J, Kiss A, Klaenhammer TR, Kobayashi I, Kong H, Kruger DH, Lacks S, Marinus MG, Miyahara M, Morgan RD, Murray NE, Nagaraja V, Piekarowicz A, Pingoud A, Raleigh E, Rao DN, Reich N, Repin VE, Selker EU, Shaw PC, Stein DC, Stoddard BL, Szybalski W, Trautner TA, Van Etten JL, Vitor JM, Wilson GG, Xu SY. 2003. A nomenclature for restriction enzymes, DNA methyltransferases, homing endonucleases and their genes. Nucleic Acids Res. 31:1805–1812 - PMC - PubMed

Publication types

Substances